Therefore, we invited 75 promising startups from the "Seoul Startup Hub M⁺" and 8 out of 10 startups selected from startups across the city of Seoul to Japan to hold a pitch event in November 2023. This is the first part of a back and forth report on the content of the pitches.
CASE 1, Lancode Corporation
Industry: Consulting, software and information processing
Industries to collaborate with: consulting, software and information processing
With its Conversational eXperience Platform (CXP), a conversational AI platform for enterprises, Rankcode aims to be the No. 1 partner in democratizing AI for enterprise customers based on its conversational AI, generative AI, enterprise cloud, and data integration capabilities. We aim to be the No. 1 partner for democratizing AI for our enterprise customers.

Lancode is a company that aims to be the number one partner in democratizing AI so that everyone can make convenient use of AI. We are growing rapidly through collaboration with Microsoft and other partners around the world. According to Gartner, more than 40% of people have experienced "making bad decisions due to lack of timely information" or "struggling with overload of information and documents," and have difficulty finding the information they need from the vast amount of documents and data.
While there has been an explosion of companies looking to solve those challenges by implementing AI, it is also true that there are high technical barriers to implementing AI. There are two major challenges that companies face when implementing AI. The first is the difficulty of collecting data from a variety of sources and tools due to data fragmentation. The other is the huge operational costs involved in building AI training data.
In other words, there is a contradiction: AI is being introduced to reduce human work, but AI is creating more human work. Rancode aims to solve this contradiction with two key words: "integration" and "automation. Specifically, Lancode supports real-time linkage with more than 90 data sources and integrates all kinds of heterogeneous data. It then automatically builds and trains multiple AI bots so that AI can be applied to business operations without the need for people to work for AI.
We have developed our own AI that can respond to the various needs of our clients so that the generated AI can be used without the need for specialists, allowing users to get the information they want in the form they want, such as text messages, chart diagrams, PDF files, etc., for a single question. Everyone can use AI simply by uploading materials and other data without complicated setup.
Today, this AI bot is trusted by large companies and startups alike as a B2B SaaS that is not only globally ready, but can also rapidly optimize and scale with a variety of corporate data. At Mercedes-Benz, it has increased the productivity of more than 400 developers, and at Chanel, it has enabled visibility into the personalized employee experience.
With numerous other uses in a variety of industries, we have a competitive advantage in the Korean market over large corporate solutions. 2024 is our year to expand into overseas markets by raising 500 million yen in Series A, with the first step being to establish corporations in Japan and France.
CASE 2, Medibel Bio Inc.
Industry sectors: Medical, Health/Healthcare, Beauty/Cosmetics
Industry sectors to collaborate: medical, health/healthcare, beauty/cosmetics, software and information processing
We want to improve the quality of life through services that enable anyone, anywhere, anytime to actively manage their health. In a market that is rapidly changing from treatment-oriented to prevention-oriented and from face-to-face to non-face-to-face, we would like to provide an interface between online and offline services to meet the needs of households, physicians, and hospitals.

We are a company that develops and provides image analysis solutions for mobile-linked AI-based digital healthcare that manages and monitors skin health through "new eyes" that see what the naked eye cannot. Our sensor-based devices measure high-quality biometric information, and our artificial intelligence solutions enable anyone to actively manage their health anytime, anywhere in 10 seconds.
There are two markets to enter: a seller-centric market for beauty and healthcare and a consumer-centric market. Both markets are large in scale, but since the effectiveness of skin care varies from person to person, easily available equipment has reliability issues from the consumer's perspective, while large scale specialized equipment is expensive and inaccessible.
Large-scale devices such as X-rays and MRI can provide accurate diagnosis, but analytical systems such as smartphones have limited diagnostic capabilities. Therefore, a multispectral system was applied as a system to digitize the naked eye. Conventional RGB systems recognize a situation from three colors, but by utilizing a multispectral system, it is possible to recognize subdivisions of a situation separately at 10 different wavelengths.
We have implemented this system and developed a product that allows for accurate skin analysis and monitoring, a system that allows consumers to easily and inexpensively diagnose skin conditions, diseases, oral management, and pet skin diagnostics through blockchain servers, AI, and mobile apps.
Currently, we are conducting POC with hospitals and related companies utilizing 200 devices. For example, in the area of medical devices, we are conducting clinical analysis of the severity of atopic dermatitis and its treatment, and with pet-related companies, we are diagnosing the skin condition of pets. We will start with these B2B skin analysis markets, and in the future, we aim to develop B2C services, focusing on overseas markets.
What we want to achieve is to enter the B2B market as a telemedicine system that integrates home and hospital, and to grow as a solution platform company that contributes to the analysis and treatment of skin, oral cavity, and ear, nose and throat With a view to going public in 2027, we want to play the role of family physician to satisfy everyone's needs. We are looking forward to being listed in 2027.
CASE 3, T.R. Inc.
Industry: Precision and medical equipment
Industries to collaborate with: precision and medical equipment, distribution, sales and marketing
The company develops and offers a smart testing (AI-based respiratory disease screening device) system that provides early diagnosis of respiratory diseases. Other products include biomechanical biomechanical tapes that aid in efficient movement, and therapeutic devices for rhinitis and respiratory diseases (to be launched).

Chronic obstructive respiratory disease (COPD), the third leading cause of death worldwide, is a disease caused by inhalation of harmful factors from smoking and air pollution such as PM2.5. In Japan, it is estimated that 95% of COPD patients are undiagnosed, despite the fact that the number of patients is increasing due to the aging of the population, and early diagnosis is becoming increasingly important.
This is a similar trend not only in Japan but throughout the world, and the situation is becoming increasingly serious due to global air pollution and increasing smoking rates in developing countries, but few institutions have lung function testing machines, and we saw this as a problem.
In the early stages of COPD, symptoms such as coughing are common, so patients usually go to primary medical institutions such as clinics rather than general hospitals. In Korea, only 16.8% of primary medical institutions have pulmonary function testing machines. The same is true in Japan. The reasons for the low ownership rate are the need for specialized personnel to perform the tests, the high cost of the equipment, and spatial limitations due to its size.
In response, we developed THE SPIROKIT, a next-generation pulmonary function testing machine that is an inexpensive device and can easily perform tests without specialized knowledge. The SPIROKIT is a handy device that fits in one hand, can perform an accurate test in up to 5 minutes, and can even predict prognosis through the use of AI. The market is sure to expand, given that South Korea will provide 5% additional compensation to institutions that conduct lung function tests from 2024, and that lung function tests will be included in health checkups from 2025.
Currently, we have a distributorship agreement with AHELS, a subsidiary of SCLH Group, a global healthcare company, to deliver our products to medical foundations, health checkup centers, and university hospitals. Overseas, we have delivered our products mainly to developing countries such as Kazakhstan and Vietnam, and we aim to achieve continuous sales by developing a new next-generation respiratory disease testing machine.
CASE 4, Leeton Technology, Inc.
Industry: Software and Information Processing
Industries to collaborate with: software and information processing, telecommunications, mass media, sales and marketing
Reaton Technologies has a vision to improve the productivity of mankind through technology and to create an environment where people can focus on their imagination and creativity. And we have a management philosophy of "AI for Everyone" so that everyone can enjoy the value generated from AI.

We are a company founded in 2021 and growing as a leading company in generative AI in South Korea. Our feature is that we can generate any content from text to images with AI. After releasing our generative AI "Wrtn (Leeton) 1.0" in October 2022, a year later in October 2023, a total of 1.2 million users have been utilizing our service.
Leeton's strength is its ability to provide the best answers based on an understanding of the user's requirements and the intent of the question. We are expanding into everyday life by selecting and executing a variety of PLUGINS such as finance, mobility, real estate, e-commerce, lodging, healthcare, jobs, and gourmet.
Our future goal is to build a generative AI ecosystem of various solutions, apps, tools, and services, so that, for example, we can provide one-stop services from online medical care and hospital reservations to car dispatch services. This will enable even elderly people with limited mobility to simply ask Leeton, "I have a cold that won't go away," and the system will provide online medical care, hospital reservations, and in some cases, ambulance dispatch.
We believe that creating a generative AI ecosystem together with various companies and players will not only improve operational efficiency and business growth, but also contribute to solving social problems. I would be happy to work with Japanese companies to create a future where everyone can live happily.
In the second part, we will provide the pitches of the remaining four startups.
About [Creww's Global Open Innovation].










